Biblio Discovery — Demo Discovery Service

1.648 hasil

Menampilkan 1–20 · 0,23 detik · RSS

Jurnal

Blood Advances

Scopus

ISSN 2473-9529 · Elsevier · 1.648 artikel di indeks

  1. Artikel Jurnal

    Diagnostic criteria for NK cell large granular lymphocyte leukemia: validation through a multicentric international study

    Cedric Pastoret; Jun Yang; David J. Feith dkk.

    Blood Advances, Vol. 10 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract: Natural killer (NK) large granular lymphocytic leukemia (LGLL) is a rare lymphoproliferative disorder lacking definitive clonality markers, complicating diagnosis and distinction from reactive NK cell expansions. We previously proposed an NK clonality score with high diagnostic accuracy…

  2. Artikel Jurnal

    Retreatment with R-CHOP–like therapy in patients with late relapse of diffuse large B-cell lymphoma

    Jean-Nicolas Champagne; Diego Villa; Alina S. Gerrie dkk.

    Blood Advances, Vol. 10 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract: Patients with diffuse large B-cell lymphoma (DLBCL) with late relapse (>2 years from diagnosis) may be treated with a second course of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)–like therapy particularly if comorbidities preclude more intensive options…

  3. Artikel Jurnal

    Germ line LCP1 mutations cause immunodeficiency with neutropenia, monocytopenia, lymphopenia, and defective cytokinesis

    Thijs van Bergen; Dennis A. Bosch; Christine Bellanné-Chantelot dkk.

    Blood Advances, Vol. 10 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract: Severe congenital neutropenia (SCN) is characterized by neutropenia, recurrent infections, and an increased leukemia risk. Multiple genetic defects that underlie SCN have been identified, but a genetic diagnosis is still lacking in a significant proportion of patients. In this study, we…

  4. Artikel Jurnal

    Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-acute myeloid leukemia activity

    Maxime Jullien; Enora Ferron; Catherine Willem dkk.

    Blood Advances, Vol. 10 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract: Haploidentical allogeneic hematopoietic stem cell transplantation (h-HSCT) is increasingly used in patients lacking an HLA-matched donor. In this context, the combination of posttransplant cyclophosphamide (PTCy) and antithymocyte globulin (ATG) effectively prevents graft-versus-host…

  5. Artikel Jurnal

    Zanubrutinib for the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies

    Constantine S. Tam; Mary Ann Anderson; Martin Šimkovič dkk.

    Blood Advances, Vol. 10 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract: Patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who harbor del(17p) and/or tumor protein p53 (TP53) mutations represent a high-risk population with a historically poor prognosis. To assess zanubrutinib efficacy and safety outcomes in patients with CLL/SLL…

  6. Artikel Jurnal

    Efficacy and safety of belumosudil as compared with best available therapy for the treatment of cGVHD in the United States

    Kevin Hall; Aleksandr Lazaryan; Mark van der Laan dkk.

    Blood Advances, Vol. 10 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract: Belumosudil was approved by the Food and Drug Administration in the United States for the treatment of relapsed/refractory chronic graft-versus-host disease (cGVHD) based on a randomized phase 2 trial comparing 2 belumosudil doses. The efficacy and safety of belumosudil vs the best…

  7. Artikel Jurnal

    Intranasal fentanyl and impact of an emergency department pain protocol for sickle cell disease on hospitalization rates

    Olufunke Y. Martin; Sean M. Thompson; Matthew Hays dkk.

    Blood Advances, Vol. 10 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract: Sickle cell disease (SCD) is an inherited red blood cell disorder with significant complications, including vaso-occlusive crisis (VOC), the most common cause of emergency department (ED) visits and hospitalizations. Pain in children with SCD is often underestimated. We evaluated the…

  8. Artikel Jurnal

    Primary and secondary stroke prophylaxis in children with sickle cell anemia: a meta-analysis

    Hemalatha G. Rangarajan; Jose A. Mejias-Figueroa; Alison Gehred dkk.

    Blood Advances, Vol. 10 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract: We conducted a pooled analysis to evaluate the effectiveness of hydroxyurea (HU), chronic blood transfusion (CBT), myeloablative allogeneic hematopoietic stem cell transplant (HCT) with a matched related donor, and revascularization surgery (RVS) in children with sickle cell anemia (SCA)…

  9. Artikel Jurnal

    Derivation and external validation of a venous thromboembolism risk prediction model in asparaginase-treated ALL

    Daniela R. Anderson; Radhika Gangaraju; Wafik George Sedhom dkk.

    Blood Advances, Vol. 10 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract: The incidence of venous thromboembolism (VTE) in patients with acute lymphoblastic leukemia (ALL) receiving asparaginase-based induction is high despite primary thromboprophylaxis. Our aim was to derive and externally validate a VTE risk prediction model in patients with ALL receiving…

  10. Artikel Jurnal

    Antibiotic risk score for acute graft-versus-host disease

    Armin Rashidi; Fei Gao

    Blood Advances, Vol. 10 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract: Certain antibiotic exposures have been associated with increased rates of acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic cell transplant (alloHCT). Using data from 2023 alloHCTs performed at our center (2010-2021), we recently developed an antibiotic risk score…

  11. Artikel Jurnal

    Efficacy and safety of vemircopan as monotherapy in patients with paroxysmal nocturnal hemoglobinuria

    Austin Kulasekararaj; Peter Browett; Antonio M. Risitano dkk.

    Blood Advances, Vol. 10 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, complement-mediated hematologic disease. We present the results of a phase 2, open-label clinical trial of vemircopan monotherapy in patients with PNH to explore the efficacy and safety of inhibiting the complement alternative pathway…

  12. Artikel Jurnal

    Heme and hemozoin induce platelet cell death through UPR-induced apoptosis and ferroptosis in vivax malaria

    Milena Tavares Gomes; Isabel M. Medeiros-de-Moraes; Adriana Vieira-de-Abreu dkk.

    Blood Advances, Vol. 10 No. 3 · 2026 · Inggris · DOAJ Scopus

    Abstract: Malaria is a highly prevalent infectious disease caused by Plasmodium parasites. Plasmodium intraerythrocytic replication leads to hemolysis-driven intermittent febrile crises in patients. In addition, the lysis of unparasitized red blood cells contributes to anemia and endotoxemia…

Menampilkan maksimal 50 halaman. Persempit pencarian dengan filter untuk hasil yang lebih spesifik.